Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
March 14, 2016 7:00 am
From NY Times: Waste in Cancer Drugs Costs $3 Billion a Year
Here’s an excerpt:
The federal Medicare program and private health insurers waste nearly $3 billion every year buying cancer medicines that are thrown out because many drug makers distribute the drugs only in vials that hold too much for most patients, a group of cancer researchers has found…
If drug makers distributed vials containing smaller quantities, nurses could pick the right volume for a patient and minimize waste…according to researchers at Memorial Sloan Kettering Cancer Center, whopublished a study on Tuesday in BMJ…
“Drug companies are quietly making billions forcing little old ladies to buy enough medicine to treat football players, and regulators have completely missed it,” said Dr. Peter B. Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering and a co-author of the study…
Some non-cancer drugs also generate considerable waste, includingRemicade, an arthritis drug sold by Johnson & Johnson for which an estimated $500 million of the drug’s $4.3 billion in annual sales comes from quantities that are thrown away, researchers found.
My take: this is another indictment of our pharmaceutical companies willful neglect of medication costs or cynical manipulation of our healthcare system.
Related blog posts:
Posted by gutsandgrowth
Categories: General Health
Tags: drug pricing, pharmaceutical companies, pharmaceutical drug costs
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
[…] Drug Waste Costing Billions. Pharmaceutical Companies Benefit […]
By How to Undermine Value Care: Lessons from Pharmaceuticals | gutsandgrowth on December 18, 2016 at 9:01 am
[…] Drug Waste Costing Billions. Pharmaceutical Companies Benefit […]
By Orphan Drugs –Very Profitable | gutsandgrowth on January 30, 2017 at 7:01 am
[…] Drug Waste Costing Billions. Who benefits? Pharmaceutical Companies […]
By Turning Liquid into Gold: A Pharmaceutical Rumpelstiltskin Story | gutsandgrowth on March 22, 2017 at 7:00 am
[…] Drug Waste Costing Billions. Who benefits? Pharmaceutical Companies […]
By Another Shady Pharmaceutical Business Practice: Citizen’s Pathway to Delay Competition | gutsandgrowth on May 19, 2017 at 7:33 am